Q-omics provides the consensus-scored MIR4655 profile across patient tissues and cancer cell-line models. MIR4655 expression is associated with patient survival in 14 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, MIR4655 is differentially expressed in 1, with the highest sampling consensus in STAD. Additionally, MIR4655 RNA expression shows 12,272 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight UVM, and STAD as cancer lineages where MIR4655 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR4655 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR4655 survival associations across molecular data types. MIR4655 RNA expression shows survival associations in the most cancer types (14). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR4655 RNA expression–survival associations across cancer types. High MIR4655 expression shows unfavorable associations in UVM, HNSC, KIRP, CESC and LIHC, but favorable associations in OV. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UVM as the clearest survival context for MIR4655 RNA expression.
This table summarizes MIR4655 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in STAD for RNA.
This table ranks reproducible tumor–normal expression differences for MIR4655. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR4655 shows higher tumor expression in STAD. The STAD box plot shows higher MIR4655 RNA expression in tumor versus normal tissue (log2 FC = +0.233, t-test p = .009).
This table shows molecular features associated with MIR4655 in patient tissues and cancer cell lines. In patient samples, MIR4655 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
